×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
ON DEMAND - Impact Patient Centered Initiatives in Clinical Trial Design and Execution
Session Chair(s)
Mary Elmer, BSN, MSN, RN
Executive Director, Patient Engagement for Oncology
Merck & Co., Inc., United States
The Patient Experience Initiative developed tools to provide more effective ways to engage with patients in design and execution of clinical studies. These tools will be presented and their impact will be discussed.
Learning Objective : Discuss patient perspectives on clinical trial access, design, conduct and post-trial follow-up, based on recent forums and collaborations; Describe publicly available tools for engaging patients in study design and measuring experiences during clinical trials; Describe how gathering patient feedback during protocol development and from clinical study patients during the study may help improve patient experience and reduce patient burden.
Speaker(s)
A Stage IV Cancer Patient's Perspective on Clinical Trials
Laura Holmes Haddad
Independent Consultant, United States
Writer and Speaker, Patient Advocate
Putting Patients at the Heart of Clinical Research: New Learnings, Solutions, and Best Practices
Pamela Tenaerts, MD, MBA
Medable, United States
Chief Scientific Officer
Multi-Stakeholder Approach to Incorporating the Patient Voice into Medicines Development
David P. Leventhal, MBA
Pfizer Inc, United States
Enterprise Clinical Trial Data Sharing Lead, Global Data Dissemination
Patient Focused Drug Development: Considerations for Clinical Trial Design and Execution
Robyn Bent, MS, RN
FDA, United States
Director, Patient Focused Drug Development, OCD, CDER
Have an account?